Screener
West Pharmaceutical Services WST Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's enterprise value?
- West Pharmaceutical Services (WST) reported enterprise value of $25.24B in Q2 2026.
- How has West Pharmaceutical Services's enterprise value changed year-over-year?
- West Pharmaceutical Services's enterprise value increased by 59.8% year-over-year, from $15.8B to $25.24B.
- What is the long-term trend for West Pharmaceutical Services's enterprise value?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's enterprise value has grown at a -1.4% compound annual growth rate (CAGR), from $20.7B to $19.33B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about West Pharmaceutical Services's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude